Skip to main content

Advertisement

Log in

False positive 18F-FDG PET/CT due to gynaecomastia

  • Image of the month
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Patten RM, Shuman WP, Teefey S. Subcutaneous metastases from malignant melanoma: prevalence and findings on CT. Am J Roentgenol 1989;152(5):1009–12

    CAS  Google Scholar 

  2. Yamada K, Brink I, Bisse E, Epting T, Engelhardt R. Factors influencing [F-18] 2-fluoro-2-deoxy-D-glucose (F-18 FDG) uptake in melanoma cells: the role of proliferation rate, viability, glucose transporter expression and hexokinase activity. J Dermatol 2005;32(5):316–34

    PubMed  CAS  Google Scholar 

  3. Wahl RL. Current status of PET in breast cancer imaging, staging and therapy. Semin Roentgenol 2001;36(3):250–60

    Article  PubMed  CAS  Google Scholar 

  4. Fukuchi K, Sasaki H, Yokoya T, Noguchi T, Goto Y, Hayashida K, et al. Ga-67 citrate and F-18 FDG uptake in spironolactone-induced gynecomastia. Clin Nucl Med 2005;30(2):105–6

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to A. I. J. Arens.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ramtahalsing, R., Arens, A.I.J., Vliegen, R.F.A. et al. False positive 18F-FDG PET/CT due to gynaecomastia. Eur J Nucl Med Mol Imaging 34, 614 (2007). https://doi.org/10.1007/s00259-006-0263-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-006-0263-7

Keywords

Navigation